Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation sequencing for lymphoid neoplasms: Real-world utility from a clinical assay.

Human pathology - 1 Jul 2026

Chen Chuan, Artymiuk Cody J, Schwab Tanya L, Feldman Andrew L, Jevremovic Dragan, McPhail Ellen D, Rech Karen L, Viswanatha David S, Hampel Paul J, Wang Yucai, He Rong, King Rebecca L

Abstract excerpt

Although next-generation sequencing (NGS) has become the standard of care in myeloid neoplasms, the utility of lymphoma NGS (LNGS) in the clinical setting has not been well established. The goal of this study was to document the real-world use of LNGS panels and assess their prognostic, predictive, and diagnostic value. A total of 384 cases were retrospectively reviewed in conjunction with pathology reports,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to High-Throughput Nucleotide Sequencing

Share to Lymphoma

Share to Predictive Value of Tests

Share to Prognosis

Share to Young Adult

Source

Identifiers

PMID: 41974312
DOI: 10.1016/j.humpath.2026.106123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation sequencing for lymphoid neoplasms: Real-world utility from a clinical assay.PMID 41974312Read ↗

Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.Semantic proximity Read ↗

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.Semantic proximity Read ↗

Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders.Semantic proximity Read ↗

LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.Semantic proximity Read ↗

Indications of next-generation sequencing in non-Hodgkin's lymphoma.Semantic proximity Read ↗

Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.Semantic proximity Read ↗

A genetic profiling guideline to support diagnosis and clinical management of lymphomas.Semantic proximity Read ↗

Applications of next-generation sequencing in hematologic malignancies.Semantic proximity Read ↗

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read ↗

Genomic profiling for clinical decision making in lymphoid neoplasmsSemantic proximity Read ↗

Molecular Monitoring of Lymphomas.Semantic proximity Read ↗

[Routine high-throughput targeted sequencing of lymphoproliferative diseases : Clinical utility and challenges].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.